7A42.4ICD-11 MMS 2026-01
Sleep-related hypoventilation due to a medication or substance
Description
Sleep-related hypoventilation due to a medication or substance is characterised primarily by chronic hypoventilation and hypercapnia due to prolonged use of medications or substances known to depress ventilatory drive and/or impair respiratory muscle mechanics (e.g. long-acting narcotics, anesthetics, sedative compounds, and muscle relaxants). Hypoxemia is commonly present as well. Hypercapnia may also be present during wakefulness in some patients. Patients can either be asymptomatic or present with complaints of dyspnea, chest tightness, or fatigue. Note: A definitive diagnosis requires objective evidence based on polysomnography with carbon dioxide (CO2) monitoring (by arterial, end-tidal or transcutaneous measures) in the context of medication or substance use that is judged to be causing the symptoms.
Index terms
- Sleep-related hypoventilation due to a medication or substance
- Sleep-related hypoventilation due to substances including medications
Exclusions from above levels
KB2A– Apnoea of newborn
Sibling codes
7A42.0– Obesity hypoventilation syndrome7A42.1– Congenital central alveolar sleep-related hypoventilation7A42.2– Non-congenital central hypoventilation with hypothalamic abnormalities7A42.3– Idiopathic central alveolar hypoventilation7A42.5– Sleep-related hypoventilation due to medical condition7A42.6– Sleep-related hypoxemia due to a medical condition7A42.Y– Other specified sleep-related hypoventilation or hypoxemia disorders7A42.Z– Sleep-related hypoventilation or hypoxemia disorders, unspecified
Foundation entity
Sleep-related hypoventilation due to a medication or substance – http://id.who.int/icd/entity/230938285
Part of: 7A42: Sleep-related hypoventilation or hypoxemia disorders › 07: Sleep-wake disorders